KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Invested Capital (2016 - 2025)

Historic Invested Capital for Cardlytics (CDLX) over the last 10 years, with Q3 2025 value amounting to $41.4 million.

  • Cardlytics' Invested Capital fell 8537.96% to $41.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.4 million, marking a year-over-year decrease of 8537.96%. This contributed to the annual value of $288.6 million for FY2024, which is 2644.37% down from last year.
  • Per Cardlytics' latest filing, its Invested Capital stood at $41.4 million for Q3 2025, which was down 8537.96% from $104.7 million recorded in Q2 2025.
  • Cardlytics' Invested Capital's 5-year high stood at $875.1 million during Q4 2021, with a 5-year trough of $41.4 million in Q3 2025.
  • Moreover, its 5-year median value for Invested Capital was $392.3 million (2023), whereas its average is $418.1 million.
  • Per our database at Business Quant, Cardlytics' Invested Capital soared by 44750.67% in 2021 and then crashed by 8537.96% in 2025.
  • Quarter analysis of 5 years shows Cardlytics' Invested Capital stood at $875.1 million in 2021, then crashed by 75.82% to $211.6 million in 2022, then skyrocketed by 85.39% to $392.3 million in 2023, then fell by 26.44% to $288.6 million in 2024, then crashed by 85.66% to $41.4 million in 2025.
  • Its last three reported values are $41.4 million in Q3 2025, $104.7 million for Q2 2025, and $110.0 million during Q1 2025.